E-Mail
(Media note: Interviews with Texas Biomed researchers are available with advanced notice. Photos and video of rhesus macaques and the Biosafety Level 3 & 4 laboratories at Texas Biomed are available upon request.)
SAN ANTONIO (April 27, 2021) - When the world was coming to grips with an emerging global pandemic a year ago, scientists at Texas Biomedical Research Institute sprang into action. The rhesus macaques at the Southwest National Primate Research Center (SNPRC) at Texas Biomed were quickly validated as models for studying vaccines designed to protect humans against SARS-CoV-2, the virus that causes COVID-19. The Pfizer-BioNTech COVID-19 vaccine was tested in this model at the Institute and has now been given to millions of people around the world.
Texas Biomed shares critical work in development of Pfizer COVID vaccine
Virtual Global Health Symposium April 29-30, 2021 will highlight role of preclinical research in vaccine development
News provided by
Share this article
Share this article
SAN ANTONIO, April 27, 2021 /PRNewswire/ When the world was coming to grips with an emerging global pandemic a year ago, scientists at Texas Biomedical Research Institute sprang into action. The rhesus macaques at the Southwest National Primate Research Center (SNPRC) at Texas Biomed were quickly validated as models for studying vaccines designed to protect humans against SARS-CoV-2, the virus that causes COVID-19. The Pfizer-BioNTech COVID-19 vaccine was tested in this model at the Institute and has now been given to millions of people around the world.
Texas Biomed shares critical work in development of Pfizer COVID vaccine prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Texas Biomed shares critical work in development of Pfizer COVID vaccine yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.